TB vaccine MTBVAC gets CDSCO nod for phase II trials
CDSCO approves Bharat Biotech's phase II clinical trial for TB vaccine in India, focusing on safety and immunogenicity.
The Hindu ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Biofabri
Clinical trials of Spanish tuberculosis vaccine MTBVAC begin in India
Clinical trials of MTBVAC, a genetically modified TB vaccine, have begun in India by Bharat Biotech and Biofabri.
The Hindu ·
BB, Biofabri tie up for novel TB vax
HYDERABAD: Bharat Biotech has partnered with Spanish biopharma player Biofabri to develop, manufacture and distribute a novel TB vaccine, MTBVAC, in more than 70 countries with a high TB incidence, primarily in Southeast Asia and sub-Saharan Africa.
The Times of India ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
The Hindu
The Times of India
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Places
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
